Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Blog

Revvityブログ

発見から治療までのイノベーションを促進

Latest

Small nuclear RNAs: biogenesis, function, and NGS-based study techniques.

NGS September 16, 2025 - 5 min read
Read
Cancer

Quantifying CAR T-cell mediated tumor killing using image-based cytometry.

September 3, 2025 - 2 min read
Read
Cancer

How conditional bispecific antibodies are advancing precision immunotherapy.

August 14, 2025 - 2 min read
Read
Cancer

Scaling up oligonucleotide discovery: accelerating therapeutic lead identification from months to weeks.

August 6, 2025 - 3 min read
Read
Cancer

Good gut feelings about the health of microbial research.

June 23, 2025 - 3 min read
Read
Cancer

Clonal cell lines or pool cell populations? Choosing the right solution to help avoid inconsistent results.

April 15, 2025 - 2 min read
Read
Cell and Gene Therapy, Biologics, Cancer

Happy birthday Cellometer Ascend – and Q&A with Charles Hernandez.

April 2, 2025 - 3 min read
Read
Cancer

The mixed lymphocyte reaction (MLR): a classic assay for modern drug immune assessment.

March 25, 2025 - 3 min read
Read
Cancer

Utilizing AlphaLISA technology to elucidate CDK2 signaling pathways in CCNE-1 amplified ovarian cancer.

March 5, 2025 - 8 min read
Read
Cancer

How Mimix™ Reference Standards are generated, and how they can support your oncology research.

February 28, 2025 - 7 min read
Read
Cancer

Lentiviral sgRNA CRISPR screening in primary human immune cells.

February 19, 2025 - 2 min read
Read
Pagination
  • Current page 1
  • ページ 2
  • ページ 3
  • ページ 4
  • Next page Next
  • Last page 最後 »

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.